dc.contributor.author | Semeere, Aggrey S. | |
dc.contributor.author | Nakanjako, Damalie | |
dc.contributor.author | Ddungu, Henry | |
dc.contributor.author | Kambugu, Andrew | |
dc.contributor.author | Manabe, Yukari C. | |
dc.contributor.author | Colebunders, Robert | |
dc.date.accessioned | 2013-01-08T07:19:52Z | |
dc.date.available | 2013-01-08T07:19:52Z | |
dc.date.issued | 2012-07-02 | |
dc.identifier.citation | Semeere, A.S., Nakanjako, D., Ddungu, H., Kambugu, A., Manabe, Y.C., Colebunders, R. (2012) Sub-optimal vitamin B-12 levels among ART-Naïve HIV positive individuals in an urban cohort in Uganda. PLoS One 7(7) | en_US |
dc.identifier.issn | 1932-6203 | |
dc.identifier.uri | doi:10.1371/journal.pone.0040072 | |
dc.identifier.uri | http://hdl.handle.net/10570/956 | |
dc.description.abstract | Malnutrition is common among HIV-infected individuals and is often accompanied by low serum levels of micronutrients. Vitamin B-12 deficiency has been associated with various factors including faster HIV disease progression and CD4 depletion in resource-rich settings. To describe prevalence and factors associated with sub-optimal vitamin B-12 levels among HIVinfected antiretroviral therapy (ART) naïve adults in a resource-poor setting, we performed a cross-sectional study with a retrospective chart review among individuals attending either the Mulago-Mbarara teaching hospitals’ Joint AIDS Program (MJAP) or the Infectious Diseases Institute (IDI) clinics, in Kampala, Uganda. Logistic regression was used to determine factors associated with sub-optimal vitamin B-12. The mean vitamin B-12 level was 384 pg/ml, normal range (200–900). Suboptimal vitamin B-12 levels (,300 pg/ml) were found in 75/204 (36.8%). Twenty-one of 204 (10.3%) had vitamin B-12 deficiency (,200 pg/ml) while 54/204 (26.5%) had marginal depletion (200–300 pg/ml). Irritable mood was observed more among individuals with sub-optimal vitamin B-12 levels (OR 2.5, 95% CI; 1.1–5.6, P = 0.03). Increasing MCV was associated with decreasing serum B-12 category; 86.9 fl (65.1) vs. 83 fl (68.4) vs. 82 fl (68.4) for B-12 deficiency, marginal and normal B-12 categories respectively (test for trend, P=0.017). Compared to normal B-12, individuals with vitamin B-12 deficiency had a longer known duration of HIV infection: 42.2 months (627.1) vs. 29.4 months (623.8; P=0.02). Participants eligible for ART (CD4,350 cells/ml) with sub-optimal B-12 had a higher mean rate of CD4 decline compared to counterparts with normal B-12; 118 (6145) vs. 22 (6115) cells/ml/year, P=0.01 respectively. The prevalence of a sub-optimal vitamin B-12 was high in this HIV-infected, ART-naïve adult clinic population in urban Uganda. We recommend prospective studies to further clarify
the causal relationships of sub-optimal vitamin B-12, and explore the role of vitamin B-12 supplementation in immune recovery. | en_US |
dc.description.sponsorship | This study was funded in part by The Flemish Interuniversity Council (Vlaamse Interuniversitaire Raad/VLIR) Grant through the Infectious Diseases Institute, Mulago Hospital Kampala. SAS was also supported by the United States National Institutes of Health Office of the Director, Fogarty International Center, Office of AIDS Research, National Cancer Center, National Eye Institute, National Heart, Blood, and Lung Institute, National Institute of Dental & Craniofacial Research, National Institute On Drug Abuse, National Institute of Mental Health, National Institute of Allergy and Infectious Diseases Health, and NIH Office of Women’s Health and Research through the International Clinical Research Scholars and Fellows Program at Vanderbilt University (R24 TW007988) and the American Relief and Recovery Act. | en_US |
dc.language.iso | en | en_US |
dc.publisher | Public Library of Science | en_US |
dc.subject | Malnutrition | en_US |
dc.subject | HIV-infected people | en_US |
dc.subject | HIV/AIDS | en_US |
dc.subject | ART | en_US |
dc.subject | Uganda | en_US |
dc.subject | Infectious Diseases Institute | en_US |
dc.subject | MJAP | en_US |
dc.subject | Antiretroviral therapy | en_US |
dc.title | Sub-optimal vitamin B-12 levels among ART-Naïve HIV positive individuals in an urban cohort in Uganda | en_US |
dc.type | Journal article, peer reviewed | en_US |